Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics
Acquisition includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogram cells in vivo with potential best-in-class profile for... Read more.
Easterly Government Properties Receives Affirmation of Investment Grade Credit Rating
Reflective of its Superior Tenancy and Conservative Balance Sheet, KBRA Affirms Easterly’s BBB Rating with Stable Outlook WASHINGTON–(BUSINESS WIRE)–Easterly... Read more.
Lazard Reports September 2025 Assets Under Management
NEW YORK–(BUSINESS WIRE)–Lazard, Inc. (NYSE: LAZ) reported today that its preliminary assets under management (“AUM”) as of September 30, 2025 totaled... Read more.
Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection
The initiative features the perspectives of adults living with schizophrenia and taking COBENFY™ (xanomeline and trospium chloride), their care partners and a... Read more.
WPP INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that WPP plc Investors with Substantial Losses Have Opportunity to Lead the WPP Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–The law firm of Robbins Geller Rudman & Dowd LLP announces that the WPP class action lawsuit seeks to represent purchasers... Read more.
BetterHelp Survey Reveals Americans Need Qualified Mental Health Support Beyond What Loved Ones Can Provide
BetterHelp launches Therapist Match Commitment and Therapist Impact Fund to ensure people get the professional care they deserve SAN JOSE, Calif.–(BUSINESS... Read more.
NW Natural Holdings Schedules Earnings Release and Conference Call for Wednesday, Nov. 5
PORTLAND, Ore.–(BUSINESS WIRE)–Northwest Natural Holding Company (NYSE: NWN) (NW Natural Holdings) announced today it will issue its third quarter and... Read more.
U.K. Public Sector Advances Digital Transformation
Digitalization reshapes delivery of government services through cloud adoption, cybersecurity, AI integration, ISG Provider Lens® report says LONDON–(BUSINESS... Read more.
Data from GNT-018-IDES Trial Supports Feasibility of imlifidase as Pretreatment in Gene Therapy Treatment for Patients With Crigler–Najjar Syndrome Who Are Immune to AAV
Results presented today at ESGCT 2025 PARIS–(BUSINESS WIRE)–Genethon, a worldwide pioneer and leader in research and development of gene therapy for... Read more.
Ant Group Shares How Digital Innovation Supports Environmental Protection at IUCN Event: The Ant Forest Story
ABU DHABI, United Arab Emirates–(BUSINESS WIRE)–By harnessing the power of digital platforms and engaging users in fun, interactive, and efficient ways,... Read more.